I4337 2 mg (Terazosin Hydrochloride 2 mg)
Pill with imprint I4337 2 mg is White & Yellow, Capsule-shape and has been identified as Terazosin Hydrochloride 2 mg. It is supplied by Teva Pharmaceuticals USA.
Terazosin is used in the treatment of benign prostatic hyperplasia; high blood pressure; hyperhidrosis and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Terazosin 2 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for I4337 2 mg
Terazosin Hydrochloride
- Imprint:
- I4337 2 mg
- Strength:
- 2 mg
- Color:
- White & Yellow
- Size:
- 16.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Antiadrenergic agents, peripherally acting
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Teva Pharmaceuticals USA
- Inactive Ingredients:
- corn starch
crospovidone
D&C Yellow No. 10
FD&C Blue No. 1
FD&C Blue No. 2
FD&C Red No. 40
gelatin
lactose monohydrate
magnesium stearate
propylene glycol
shellac
ferrosoferric oxide
magnesium silicate
titanium dioxide
D&C Red No. 33
aluminum oxide
Note: Inactive ingredients may vary.
More about terazosin
- Terazosin Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 35 Reviews
- Drug class: antiadrenergic agents, peripherally acting
Consumer resources
Other brands: Hytrin
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
